Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results

Core Viewpoint - Twist Bioscience Corporation announced its financial results and business highlights for the first quarter of fiscal 2026, which ended on December 31, 2025 [1]. Financial Results - The detailed fiscal first quarter 2026 earnings report and investor presentation are available on the company's Investor Relations page [2]. Conference Call - The company will hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss financial results and provide business updates [3]. Company Overview - Twist Bioscience focuses on serving customers in various fields such as medicine, agriculture, industrial chemicals, and defense, utilizing synthetic DNA tools to improve lives and sustainability [4]. Technology Platform - The company offers an innovative silicon-based DNA Synthesis Platform that provides precision at an unprecedented scale, enabling cost-effective and rapid synthesis, sequencing, and therapeutics discovery [5].